Comparator: placebo / Duration of Treatment - 1 day

DRUG2 trials

Sponsors

Organon and Co

Conditions

Migraine

Phase 3

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)

CompletedNCT00111722

Organon and CoMigraine

Start: 2005-05-27End: 2006-02-23Updated: 2024-08-14

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)

CompletedNCT00111709

Organon and CoMigraine

Start: 2005-05-27End: 2006-02-26Updated: 2024-08-14